Antony Raphel Joy

Antony Raphel Joy

Auto-generated profile, based on publicly available information

Antony Raphel Joy

Department of Gastroenterology, Hamad Medical Corporation, Doha, Qatar

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2021 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
TPTheresa Paul
Theresa Paul
AJAntony Raphel Joy
Antony Raphel Joy
HAHussam Abdel Rahman S. Alsoub
Hussam Abdel Rahman S. Alsoub
JPJessiya Veliyankodan Parambil
Jessiya Veliyankodan Parambil
Clinical manifestations and complications of SARS-CoV-2 are still emerging and variant. Gastrointestinal (GI) manifestations and complications are hugely under-recognized. The presence of angiotensin converting enzyme-2 receptors in the intestinal enterocytes, the receptors primarily involved in the pathogenesis of COVID-19 pneumonia, maybe the key factor contributing to the pathogenesis of GI manifestations. Ischemic colitis, although the most common ischemic pathology of the GI tract, is relatively rare, occurring as a result of colonic hypoperfusion. The innumerable causes of colonic ischemia are categorized into occlusive and nonocclusive pathologies. Here, we have discussed a case of severe COVID-19 pneumonia, developing ischemic colitis, as a rare GI complication. The cause of ischemia in COVID-19 pneumonia is multifactorial, including hypercoagulable state, coagulopathy leading to thromboembolic complications, and use of vasopressors in severely ill patients with hemodynamic compromise.